P07711 (CATL1_HUMAN) Homo sapiens (Human)

Procathepsin L UniProtKBInterProSTRINGInteractive Modelling

333 aa; Sequence (Fasta) ; (Isoform 3); 3 identical sequences: Pan troglodytes: A0A6D2WE91, H2QXF0; Pan paniscus: A0A2R9ACG6

Available Structures

64 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of cysteine protease inhibitor, chagasin, in complex with human cathepsin L Heteromer
Q966X9;
113-333
99.55NAG;NA;CL;
Unreduced cathepsin L in complex with stefin A Heteromer
P01040;
114-333
99.09
CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L Heteromer
P04233;
114-333
100NAG;
Cathsilicatein, a chimerahomo-4-mer114-333
92.53SO4;
Crystal structure of human cathepsin L in complex with the vinyl sulfone inhibitor K777homo-4-mer114-333
99.55D1R;PG4; 12×EDO;PEG;DMS;PGE;
Crystal structure of human cathepsin L after reaction with the bound ketoamide inhibitor 13bhomo-4-mer114-333
99.55KH0; 11×DMS;PEG;PG4; 10×EDO;PGE;
Caught in the Act: The Crystal Structure of cleaved Cathepsin L bound to the active site of Catheps…homo-2-mer113-333
99.06SO4;GOL;
CATHEPSIN L IN COMPLEX WITH AC1115homo-2-mer114-333
100.0W28;
Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized …homo-2-mer114-333
100
HUMAN CATHEPSIN L APO FORM WITH ZNhomo-2-mer114-333
100ZN;GOL;ACT;
Crystal structure of mature apo-Cathepsin L C25A mutanthomo-2-mer114-333
99.54NAG;GOL;SO4;NA;
CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-17-oxa-4-azatricyclo[16…homo-2-mer114-333
100.0C7Q;
Structure of a proline specific mutant of human cathepsin Lmonomer18-333
98.4GOL; 12×EOH;PEG;EDO;PGE;
CRYSTAL STRUCTURE OF PROCATHEPSIN Lmonomer18-333
99.37
Structure of mutant human cathepsin L, engineered for GAG bindingmonomer18-333
97.4514×GOL;CL;NA;PO4; 10×POL;PGE;EOH;EDO;
CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORMmonomer22-333
98.7
Structural Basis for Irreversible Inhibition of Human Cathepsin L by a Diazomethylketone Inhibitormonomer113-333
100I0X;
Structural Basis for Reversible and Irreversible Inhibition of Human Cathepsin L by their Respectiv…monomer113-333
100I0Y;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100XU3;BTB;CL;
CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2…monomer114-333
100.07KN;EDO;
CATHEPSIN L IN COMPLEX WITH 4-[cyclopentyl(imidazo[1,2-a]pyridin-2-ylmethyl)amino]-6-morpholino-1,3…monomer114-333
100.07KH;EDO;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0DJT;GOL;
CATHEPSIN L IN COMPLEX WITH 4-[1,3-benzodioxol-5-ylmethyl(2-phenoxyethyl)amino]-5-fluoropyrimidine-…monomer114-333
100.0GH4;EDO;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0424;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0YJ2;GOL;
Crystal structure of cathepsin L in complex with AZ12878478monomer114-333
99.55NOW;PG4;ACT;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0YJ8;GOL;
Crystal structure of human Cathepsin L in complex with covalently bound Calpeptinmonomer114-333
99.55PEG;PGE;EDO;RN2;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0YJ9;GOL;
CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyc…monomer114-333
100.0C3E;GOL;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100YJ9;GOL;
Crystal structure of human cathepsin L with covalently bound Cathepsin L inhibitor IVmonomer114-333
99.55L2F;PEG;EDO;DMS;
CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2…monomer114-333
100.0GOL;5T9;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
99.53424;
Crystal structure of human Cathepsin L in complex with covalently bound MG132monomer114-333
99.55ALD;PEG;
Crystal structure of human cathepsin L with covalently bound calpain inhibitor VImonomer114-333
99.55JQO;DMS;
Crystal structure of human cathepsin L with covalently bound aloxistatin (E-64D)monomer114-333
99.55E6D;1PE;PG4;DMS;PEG;PGE;EDO;
Crystal structure of human cathepsin L in complex with covalently bound CLIK148monomer114-333
99.55KXL;PG4;1PE;DMS;PEG;
CATHEPSIN L WITH A NITRILE INHIBITORmonomer114-333
100.0XU5;GOL;FLC;
Crystal structure of apo human Cathepsin Lmonomer114-333
99.55PEG;PGE;EDO;
Crystal structure of human cathepsin L with covalently bound E-64monomer114-333
99.55E64;PEG;
Crystal structure of human Cathepsin L after incubation with Sulfo-Calpeptinmonomer114-333
99.55PEG;RN2;
Human cathepsin L after reaction with the thiocarbazate inhibitor CID 16725315monomer114-333
99.55TXH;EDO;PG4;
Crystal structure of human cathepsin L in complex with calpain inhibitor XIImonomer114-333
99.55PGE;M6L;DMS;
Crystal structure of human Cathepsin L with covalently bound Calpain inhibitor IIImonomer114-333
99.55L3F;PEG;PGE;PG4;
Crystal structure of human Cathepsin L in complex with covalently bound GC376monomer114-333
99.55PEG;NA;PGE;CL;UED;
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co…monomer114-333
100.0NSY;
Crystal structure of human cathepsin L in complex with covalently bound MG-101monomer114-333
99.55PGE;NA;
Human cathepsin L in complex with covalently bound CA-074 methyl estermonomer114-333
99.55WRH;PEG;EDO;
Crystal structure of human cathepsin L interacting with tosyl phenylalanyl chloromethyl ketone (TPC…monomer114-333
99.55TQ8;EDO;PEG;DMS;PGE;PG5;VLF;
Crystal structure of human cathepsin L with CAA0225monomer114-333
99.55L2X;NA;PEG;
Crystal structure of human cathepsin L forming a thiohemiacetal with N-Boc-2-aminoacetaldehydemonomer114-333
99.55OYU;PGE;DMS;EDO;PEG;NA;
The crystal structure of human CtsL in complex with 14cmonomer114-333
100DMS;KJ0;
Crystal structure of CTSL in complex with E64dmonomer114-333
100.0E6D;
CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17…monomer114-333
100C7T;ZN;CL;
Crystal structure of CTSL in complex with K777monomer114-333
100ZN;CAC;0IW;
Exploring inhibitor binding at the S subsites of cathepsin Lmonomer114-333
100.0OPT;
CATHEPSIN L with AZ13010160monomer114-333
99.53BD3;
The crystal structure of human CtsL in complex with 14amonomer114-333
10089B;
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co…monomer114-333
100.0NSX;
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors (c…monomer114-333
100.0NSZ;
Crystal structure of mature apo-Cathepsin L C25A mutant in complex with Gln-Leu-Ala peptidemonomer114-333
99.55NAG;
TRIAZINE CATHEPSIN INHIBITOR COMPLEXmonomer114-333
100.0GOL;V65;
The crystal structure of human CtsL in complex with 14bmonomer114-333
10089K;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6jd8.1.Amonomer0.8718-333
98.42

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 36jd8.1.Amonomer0.881-278
98.20